Sfoglia per Autore
Short- and Long-Term Effects on Glucose Control of Nonadherence to Insulin Therapy in People With Type 2 Diabetes An In Silico Study
2024 Visentin, Roberto; Cobelli, Claudio; Sieber, Jochen; Dalla Man, Chiara
Tailoring the Padova Type 2 Diabetes Simulator for Treatment Guidance in Target Populations
2024 Visentin, Roberto; Schiavon, Michele; Bonet, Jacopo; Riz, Michela; Wagenhuber, Britta; Man, Chiara Dalla
Smart Insulin Therapy Initiation In Insulin-Naive Subjects With Type 2 Diabetes Using Machine Learning
2023 Bonet, Jacopo; Visentin, Roberto; DALLA MAN, Chiara
Model Assessment of Doxorubicin Pharmacokinetics in Multiple Myeloma
2023 Baldan, M.; Da Ros, F.; Mazzucato, M.; Pedersen, M. G.; Visentin, R.
A PK/PD Simulation Model for Supporting Doxorubicin Therapy in Multiple Myeloma
2023 Andrean, D.; Doshmanziari, R.; Da Ros, F.; Mazzucato, M.; Pedersen, M. G.; Visentin, R.
SMART INSULIN THERAPY INITIATION IMPROVES GLUCOSE CONTROL IN INSULIN‐NAÏVE SUBJECTS WITH TYPE 2 DIABETES
2023 Bonet, J.; Visentin, R.; Vettoretti, M.; Facchinetti, A.; Dalla Man, C.
Modeling Doxorubicin Pharmacokinetics in Multiple Myeloma Suggests Mechanism of Drug Resistance
2023 Doshmanziari, Roya; Ros, Francesco Da; Mazzucato, Mario; Pedersen, Morten Gram; Visentin, Roberto
Modeling Doxorubicin Treatment Effect in Multiple Myeloma
2023 Andrean, D.; Da Ros, F.; Mazzucato, M.; Pedersen, M. G.; Visentin, R.
Smart Titration of Long-Acting Insulin in Insulin-Naïve Type 2 Diabetic Subjects
2023 Bonet, Jacopo; Visentin, Roberto; Vettoretti, Martina; Facchinetti, Andrea; DALLA MAN, Chiara
Increased Insulin Secretion and Glucose Effectiveness in Obese Patients with Type 2 Diabetes following Bariatric Surgery
2023 Visentin, Roberto; Brodersen, Katrine; Richelsen, Bjørn; Møller, Niels; Dalla Man, Chiara; Pedersen, Andreas Kristian; Abrahamsen, Jan; Holst, Jens Juul; Nielsen, Michael Festersen
1426-P: Increased Insulin Secretion and Glucose Effectiveness Result in Improved Glucose Tolerance in Obese Subjects Two Months after Gastric Bypass and Sleeve
2022 Visentin, Roberto; Brodersen, Katrine; Richelsen, Bjørn; Moller, Niels; Man, CHIARA DALLA; Nielsen, MICHAEL F.
IP-IP PADOVA SIMULATOR: INTRAPERITONEAL INSULIN DELIVERY AND GLUCOSE SENSING
2022 Lo Presti, J; Visentin, R; Magni, L; Galderisi, A; Cobelli, C; Toffanin, C
RESIDUAL B-CELL FUNCTION IN SUBJECTS WITH TYPE 2 DIABETES PROTECTS FROM NON-ADHERENCE TO INSULIN THERAPY VERSUS SUBJECTS WITH TYPE 1 DIABETES
2022 Visentin, R; Cobelli, C; Sieber, J; Dalla Man, C
Editorial: Recent Advances in Computer Simulation for Diabetes Treatment and Care
2022 Colmegna, P.; Toffanin, C.; Cescon, M.; Visentin, R.
A software interface for in silico testing of type 2 diabetes treatments
2022 Visentin, R.; Cobelli, C.; Dalla Man, C.
Glucose Controlin Type 2 Diabetes: In Silico Study of Sub-Optimal Adherence to Insulin Therapy
2022 Visentin, R.; Cobelli, C.; Sieber, J.; Man, C. D.
A Novel Method for Generation of In Silico Subjects with Type 2 Diabetes
2021 Visentin, R.; De Lazzari, M.
Modeling Pharmacokinetics of Doxorubicin in Multiple Myeloma Cells
2021 Giaretta, A.; Da Ros, F.; Mazzucato, M.; Pedersen, M. G.; Visentin, R.
Improved postprandial glucose metabolism in type 2 diabetes by the dual glucagon-like peptide-1/glucagon receptor agonist SAR425899 in comparison with liraglutide
2021 Schiavon, M.; Visentin, R.; Gobel, B.; Riz, M.; Cobelli, C.; Klabunde, T.; Dalla Man, C.
Determinants of hepatic insulin clearance – Results from a Mendelian Randomization study
2021 Lamprinou, A.; Willmann, C.; Machann, J.; Schick, F.; Eckstein, S. S.; Dalla Man, C.; Visentin, R.; Birkenfeld, A. L.; Peter, A.; Stefan, N.; Haring, H. -U.; Fritsche, A.; Heni, M.; Wagner, R.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile